HRT Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

HRT Financial’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48M	Buy	177,780 +153,646	+637%	+$4.89M	0.01%	923
2026 Q1	$637K	Buy	+24,134	New	+$707K	﹤0.01%	2341
2025 Q2	–	Sell	-18,626	Closed	-$386K	–	2567
2025 Q1	$386K	Buy	+18,626	New	+$468K	﹤0.01%	1632
2024 Q4	–	Sell	-221,698	Closed	-$5.67M	–	2404
2024 Q3	$5.67M	Buy	221,698 +121,179	+121%	+$3.09M	0.03%	408
2024 Q2	$2.36M	Buy	+100,519	New	+$2.54M	0.01%	666
2023 Q2	–	Sell	-20,047	Closed	-$602K	–	2434
2023 Q1	$602K	Sell	20,047 -7,730	-28%	-$240K	0.01%	1240
2022 Q4	$784K	Buy	+27,777	New	+$882K	0.01%	1113
2022 Q3	–	Sell	-78,061	Closed	-$2.46M	–	2759
2022 Q2	$2.46M	Sell	78,061 -76,985	-50%	-$2.69M	0.03%	488
2022 Q1	$7.12M	Buy	155,046 +143,344	+1,225%	+$6.83M	0.05%	201
2021 Q4	$716K	Sell	11,702 -165,873	-93%	-$11.5M	﹤0.01%	1484
2021 Q3	$13.3M	Sell	177,575 -185,018	-51%	-$15.5M	0.08%	119
2021 Q2	$33.5M	Buy	+362,593	New	+$30.8M	0.31%	46
2021 Q1	–	Sell	-149,385	Closed	-$13.9M	–	2666
2020 Q4	$13.9M	Buy	+149,385	New	+$11.9M	0.28%	60

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HRT Financial's ARKG Position: Q2 2026 in Review

HRT Financial increased its ARK Genomic Revolution ETF (ARKG) stake by 637% in Q2 2026, buying an estimated $4.89M and bringing the position to 177,780 shares worth $7.48M. The position accounts for 0.01% of the portfolio, ranked #923.

HRT Financial first reported a position in ARKG in Q4 2020 and has held it in 13 quarters since. The position peaked at $33.5M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

HRT Financial held 177,780 shares of ARK Genomic Revolution ETF worth $7.48M as of Q2 2026.
HRT Financial bought 153,646 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $4.89M.
ARK Genomic Revolution ETF made up 0.01% of HRT Financial's portfolio in Q2 2026, its #923 holding.
HRT Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 13 quarters since.
HRT Financial's ARK Genomic Revolution ETF position peaked at $33.5M in Q2 2021.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.